Solid HVAD Data at ISHLT

Posted on April 11th, 2011  

Canaccord Genuity rates HeartWare a “buy.” Important new data shows six-month survival remains outstanding.

2011 04-11 HTWR – ISHLT takeaways – Buy – JMills – CG – 4 18 11